Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > January 2015

« Previous month Next month »

Google picks Biogen Idec MS project for research partnership

29-Jan-2015 - Google and Biogen Idec are teaming up to crack multiple sclerosis, the latest crossover between pharma and the wearables world.


Novartis: New cost-saving unit will not target manufacturing network

29-Jan-2015 - Novartis has divested, restructured, or mothballed 24 manufacturing plants since 2010 but says its new NBS cost-saving business will not focus on streamlining and consolidating sites.

Provectus seeking Indian PV-10 API patent and says it is “more than a match” for skin cancer competitors

29-Jan-2015 - Provectus Biopharmacetuicals is seeking an Indian patent and partner for PV-10 and says it is 'more than a match' for skin cancer competitors like Merck & Co and Bristol-Myers Squibb....

Johnson Matthey posts higher Q3 API profits; Pfizer patent spat continues

28-Jan-2015 - Johnson Matthey saw demand for ADHD APIs increase in the third quarter, while sales of its pain management ingredients and bulk opiates declined.

China patent gives Provectus green light to find partner for melanoma candidate, PV-10

27-Jan-2015 - China has told Provectus Biopharmaceuticals it will grant a patent for the method used to make the API in its skin cancer drug candidate, PV-10.


Pfizer considers splitting company or going after M&A

27-Jan-2015 - Pfizer says it is considering breaking up the company in 2015, or alternatively continuing its pursuit of a major acquisition.


Ebola: which are the leading vaccine candidates?

27-Jan-2015 -'s interactive guide to the world's most promising Ebola vaccines.

Hospira 'committed to quality' as total recall count hits 40 since 2012

27-Jan-2015 - A human hair found in a vial of Sodium Chloride Injection has led to the fortieth recall in three years for Hospira.

Catalent to offer integrated services in Germany through softgel expansion

27-Jan-2015 - A coating and packaging expansion at a facility in Germany will feed the demand for end-to-end softgel services, Catalent Pharma Solutions says.

Halal and Kosher stamps of approval for pregnancy drug

26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an...

US Senator proposes NIH to be funded through Big Pharma ‘swear jar’

26-Jan-2015 - Pharma firms that break the law could be fined one percent of their blockbuster drug revenues if proposed US legislation is introduced.

News in brief

30 months for smuggler of Roche cancer drugs which lacked API

26-Jan-2015 - A second man has received a prison sentence after counterfeit vials of a Roche cancer drug containing no API were seized in 2012.

People on the Move

CEOs found for BSM and Repligen

26-Jan-2015 -

Syrzia win may land pharma with more Greek debts, analyst

26-Jan-2015 - Syriza's election victory may prompt drugmakers already burdened with unpaid Greek bills to rethink their presence in the country according to one analyst.  

BASF to take on Asian PVP producers and target generics firms with new capacity in China

23-Jan-2015 - BASF will spend €56m ($62m) to increase production capacity for the excipient PVP by expanding existing plants and introducing manufacturing capabilities at its facility in Shanghai, China.

FDA's wearables guidance could slow pharma adoption in short-term, says analyst

22-Jan-2015 - Draft guidance distinguishing wearable medical devices from ‘general wellness’ devices could slow pharma’s adoption of such data in the short-term, according to an analyst.

Antibiotics "a terrible business model" for Pharmas expert tells Davos

22-Jan-2015 - Drug industry execs at the World Economic Forum in Davos, Switzerland were told they are no longer best placed to develop antibiotics by a panel who said Governments should lead...

State of the Union: Obama’s fast-track trade plans divide pharma

22-Jan-2015 - President Obama in his State of the Union address has called for the power to personally make stronger trade agreements – bringing divisive EU deal TTIP closer to adoption and...

Pharma turning to injectable systems to protect biologics, says Unilife

22-Jan-2015 - Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO,  Alan Shortall.

Lonza benefits from outsourcing growth as Swiss franc fluctuations stall 2015 projections

22-Jan-2015 - Biopharma outsourcing growth has helped to boost the bottom line of Lonza, the world’s largest manufacturer of drug ingredients, though a topsy-turvy Swiss franc has caused the company to hold...

EMA supply interuption rules need clarification says industry; NGO says high prices cause shortages

21-Jan-2015 - Rules governing when drugmakers should warn regulators about supply interruptions need to take mitigation plans into account according to European industry groups.

EMA expands generic assessment pilot globally in response to industry

21-Jan-2015 - The EMA has responded to feedback from generic drugmakers by broadening an assessment sharing pilot to regulators outside the EU.

Teva: More biomanufacturing space needed to tap biologics opportunities

21-Jan-2015 - Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.

Novozymes predicts half-life boost for pharma business, but lets long term rev forecast slide on oil prices

20-Jan-2015 - Novozymes finished 2014 with higher pharma revenues thanks in part to GSK's adoption of its albumin half-life extension technology, Veltis.

Insulin in sea snail venom could be used by drug developers

20-Jan-2015 - Venom produced by sea snails could be used in designing human insulin analogues or as painkiller drugs, according to a University of Utah scientist.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...